Table 1. Demographic and clinical characteristics of study subjects at enrolment.
| Variables | ENL (n = 46) n (%) | LL (n = 31) n (%) | |
|---|---|---|---|
| Sex | Male | 31 (67.4) | 23 (74.2) |
| Female | 15 (32.6) | 8 (25.8) | |
| Median age in years (range) group | 27.5 (18–56) | 25.0 (18–60) | |
| Median age in years (range) Male | 28 (18–56) | 26.0 (18–60) | |
| Median age in years (range) Female | 26.7 (18–35) | 21.0 (18–30) | |
| MDT status | No previous MDT | 10 (21.7) | 22 (71.0) |
| Current | 9 (19.6) | 8 (25.8) | |
| Completed | 27 (58.7) | 1 (3.2) | |
| HIV status | Positive | 0 (0.0) | 0 (0.0) |
| Negative | 46 (100.0) | 31 (100.0) | |
| Duration of current ENL symptom (Episode) Mean ± SE [days] | 6.8 ±0.491 (range: 1–15) | - | |
| Clinical status at recruitment | |||
| ENL type | Acute | 23 (50.0) | - |
| Recurrent | 5 (10.9) | - | |
| Chronic | 18 (39.1) | - | |
| LL type | New | - | 23 (74.2) |
| Relapse | - | 5 (16.1) | |
| Defaulter | - | 3 (9.7) | |
| BI at diagnosis, Mean ± SE (range) | |||
| ENL | Acute | 3.9 ±0.205 (2–6) | - |
| Recurrent | 4.9 ±0.409 (4–6) | - | |
| Chronic | 3.7 ±0.103(3–4) | - | |
| LL | Untreated (new) | 4.1 ±0.259 (2–6) | |
| Relapse | 4.2 ±0.330 (4–5) | ||
| Defaulter | 4.9 ±0.150 (4–5) |